What's new in general surgery: Endocrine surgery

Journal of the American College of Surgeons

Volumn 195, Issue 3, 2002, Pages 364-371

  McHenry, Christopher R ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROID HORMONE;

ADRENAL DISEASE; ANESTHESIA INDUCTION; CANCER SURGERY; CLINICAL PRACTICE; ENDOCRINE SURGERY; INSULINOMA; LARYNGEAL NERVE; MINIMALLY INVASIVE SURGERY; NERVE INJURY; PANCREAS SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID SURGERY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUMOR VOLUME;

EID: 0036714571     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01307-8     Document Type: Article

References (48)

1. Local/regional anesthesia for thyroidectomy: Evaluation as an outpatient procedure
2. Characteristics of patients having thyroid surgery under regional anesthesia
3. Comparison between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy: A prospective randomized study
4. Laryngeal nerve injury in surgery for benign thyroid diseases: Effect of nerve dissection and impact of individual surgeon in more than 27,000 nerves at risk
5. Patient volumes and complications in thyroid surgery
6. Volume standards for high-risk surgical procedures: Potential benefits of the Leapfrog initiative
7. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy
8. Effect of training on the incidence of nerve damage in thyroid surgery
9. Safety and efficacy of total thyroidectomy in hands of endocrine surgery trainees
10. Refined use of scintigraphy in the evaluation of nodular thyroid disease
11. The results of ultrasound-guided fine-needle aspiration biopsy for evaluation of nodular thyroid disease
12. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma
13. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography
14. Cancer statistics, 2002
15. Immediate causes of death in thyroid carcinoma: Clinicopathological analysis of 161 fatal cases
16. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
17. Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A (TSA), a histine deacetylase (HDAC) inhibitor
18. Invited commentary: Are specific inherited mutations important in clinical management of hereditary cancer syndromes?
19. Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers
20. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement
21. Do the National Institutes of Health Consensus Guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism?
22. Long-term health risk of primary hyperparathyroidism: The effect of surgery
23. Premature death in patients operated on for primary hyperparathyroidism
24. Survival and renal function in untreated hypercalcemia. Population-based cohort study with 14 years of follow-up
25. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy
26. The influence of surgery on the risk of death in patients with primary hyperparathyroidism
27. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism
28. Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism
29. Hyperparathyroidism in multiple endocrine neoplasia Type I: Surgical trends and results of 256-patient series from Groupe d'Etude des Neoplasies Endocriniennes Multiples Study Group
30. Reoperations for hyperparathyroidism in multiple endocrine neoplasia type I
31. Subtotal parathyroidectomy in renal failure: Still needed after all these years
32. Refractory renal hyperparathyroidism: Clinical features and outcome of surgical therapy
33. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism
34. Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism
35. Primary aldosteronism: Are we diagnosing and operating on too few patients?
36. Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile and molecular biology
37. Iatrogenic pheochromocytomatosis: A previously unreported result of laparoscopic adrenalectomy
38. Biochemical diagnosis of pheochromocytoma: Which test is best?
39. Biochemical diagnosis of pheochromocytoma. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
40. Germ-line mutations in nonsyndromic pheochromocytoma
41. Adrenalectomy for familial pheochromocytoma in the laparoscopic era
42. Intraoperative ultrasound and preoperative localization detects all occult insulinomas
43. Pitfalls in the surgical treatment of insulinoma
44. Laparoscopic ultrasonography for resection of insulinomas
45. Rapid insulin assay for intraoperative confirmation of complete resection of insulinomas
46. Intraoperative insulin measurement during surgical management of insulinomas
47. Role of intraoperative insulin monitoring in surgical management of insulinoma
48. Duodenal carcinoid tumors: How aggressive should we be?